The Role of Adherence to Antiretroviral Therapy in the Management of HIV Infection
- 1 June 2007
- journal article
- review article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 45 (Supplement) , S14-S18
- https://doi.org/10.1097/qai.0b013e3180600766
Abstract
Despite multiple studies demonstrating the relation between the success of highly active antiretroviral therapy (HAART) and adherence, inadequate adherence continues to be one of the most frequent reasons for poor treatment outcomes and/or lack of sustained treatment benefits. Interventions targeting patient-related social and psychologic barriers to adherence and issues related to mental health and substance abuse and access to health care may ameliorate their negative impact on adherence. Specific drug-related factors that influence adherence such as pill burden, dosing frequency, food requirements, and acute tolerability and safety concerns, however, are further issues that must be considered to optimize adherence. Fortunately, the availability of once-daily and coformulated agents with simple dosing requirements may help to improve adherence, and thereby make the difference between success and failure of HAART for some patients. A better understanding of adherence and its determinants and how to define specific goals in a given clinical setting are keys for clinicians to become more effective partners with patients in the achievement and maintenance of long-term virologic suppression and, more importantly, long-term health.Keywords
This publication has 38 references indexed in Scilit:
- Literacy, self-efficacy, and HIV medication adherencePatient Education and Counseling, 2007
- Directly Administered Antiretroviral Therapy in Methadone Clinics Is Associated with Improved HIV Treatment Outcomes, Compared with Outcomes among Concurrent Comparison GroupsClinical Infectious Diseases, 2006
- To Take or Not to Take: Decision-Making About Antiretroviral Treatment in People Living with HIV/AIDSAIDS Patient Care and STDs, 2006
- Discordant Immunologic and Virologic Responses to Highly Active Antiretroviral Therapy Are Associated With Increased Mortality and Poor Adherence to TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
- Relation between literacy and HIV treatment knowledge among patients on HAART regimensAIDS Care, 2005
- Modeling the HIV Protease Inhibitor Adherence–Resistance Curve by Use of Empirically Derived EstimatesThe Journal of Infectious Diseases, 2004
- The Impact of Adherence on CD4 Cell Count Responses Among HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/LAnnals of Internal Medicine, 2003
- Mortality and progression to AIDS after starting highly active antiretroviral therapyAIDS, 2003
- Directly Administered Antiretroviral Therapy in the Treatment of HIV Infection: Benefit or Burden?AIDS Patient Care and STDs, 2002